- Citations, last 5 years
- 82
- Works, last 5 years
- 3
- h-index
- 15
- Scientists listed
- 1
- Grants since 2016
- 10
Grants received
2018–2022 · research · R44
Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer.
Mariusz Waldemar Szkudlinski · Trophogen (United States) · funded by National Institutes of Health
2018–2020 · research · R44
Development of Novel and Affordable Neoglycosylated, Long Acting Superactive Analog of Human FSH for Infertility
Mariusz Waldemar Szkudlinski · Trophogen (United States) · funded by National Institutes of Health
2018–2021 · research · R44
Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer.
Mariusz Waldemar Szkudlinski · Trophogen (United States) · funded by National Institutes of Health
2018–2020 · research · R44
Development of Novel and Affordable Neoglycosylated, Long Acting Superactive Analog of Human FSH for Infertility
Mariusz Waldemar Szkudlinski · Trophogen (United States) · funded by National Institutes of Health
2018–2019 · research · R44
Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer.
Mariusz Waldemar Szkudlinski · Trophogen (United States) · funded by National Institutes of Health
2018–2023 · research · R44
Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer.
Mariusz Waldemar Szkudlinski · Trophogen (United States) · funded by National Institutes of Health
2017–2021 · research · R44
Novel Recombinant High-Affinity, Long- and Dual-Acting Equine CG Analogs for Improved and More Ethical Reproduction in Pigs and Cattle
Mariusz Waldemar Szkudlinski · Trophogen (United States) · funded by National Institutes of Health
2017–2018 · research · R44
Development of Novel and Affordable Neoglycosylated, Long Acting Superactive Analog of Human FSH for Infertility
Mariusz Waldemar Szkudlinski · Trophogen (United States) · funded by National Institutes of Health
2017–2023 · research · R44
Novel Recombinant High-Affinity, Long- and Dual-Acting Equine CG Analogs for Improved and More Ethical Reproduction in Pigs and Cattle
Mariusz Waldemar Szkudlinski · Trophogen (United States) · funded by National Institutes of Health
2017–2018 · research · R43
Novel Recombinant High-Affinity, Long- and Dual-Acting Equine CG Analogs for Improved and More Ethical Reproduction in Pigs and Cattle
Mariusz Waldemar Szkudlinski · Trophogen (United States) · funded by National Institutes of Health